Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
Lantheus will present new radiodiagnostic data at the 2026 SNMMI Annual Meeting in Los Angeles, featuring two distinct studies. An oral presentation on June 2 will cover the diagnostic performance of 18F-GP1 PET/CT for acute deep vein thrombosis, based on a Phase 2, open-label, non-randomized study led by researchers at Asan Medical Center.
Key figures
- Drug Name
- Piflufolastat F18, 18F-GP1
- Phase Of Trial
- Phase 2
- Conference
- 2026 SNMMI Annual Meeting
- Presentation types
- ["Poster","Oral Presentation"]
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.